XBKK
EKH
Market cap120mUSD
Nov 12, Last price
5.05THB
Name
Ekachai Medical Care PCL
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ekachai Medical Care Public Company Limited, along with its subsidiaries, operates the Ekachai hospital in Thailand. This facility provides a comprehensive range of medical services, including specialized areas such as plastic surgery, orthopedics, ophthalmology, and general surgery, as well as fertility and genetic treatments. It also caters to family health with pediatric, obstetrics, and gynecology services, and operates a dedicated child and teen development center. General medical care is available through its clinic, emergency services, and health promotion programs. Additional offerings include hemodialysis, dental care, physical therapy, aesthetic and dermatology services, mobile check-ups, and pre-employment screenings. The company was founded in 2003 and has its headquarters in Muang, Thailand.
Key people
Amnaj Eur-Areemitr
Hospital Director, Executive Director · since 2021
Amnuay Oerareemitr
Executive Chairman of the Board, Chief Executive Officer · since 2025
Kanchana Oerareemitr
Executive Director · since 2021
Wanlop Popiantong
Executive Director · since 2021
Orasa Tangsajjapoj
Executive Director · since 2021
Suthipong Tangsajjapoj
Executive Vice President, Assistant of Hospital Director - Accounting and Finance, Executive Director · since 2021
Penrung Laohasom
Assistant Hospital Director - Quality Control Division · since 2021
Kaweechai Lertussavarat
Deputy Hospital Director - Medical Division · since 2021
Nittha Oerareemitr
Assistant Hospital Director - Nursing Staff Organization · since 2019
Pichamonch Patanapoonyapirom
Deputy Hospital Director - Administrative Division · since 2021
Pattra Lertpunyaphol
Company Secretary · since 2023
Manit Jumpa
Independent Director · since 2025
Sirichai Limsakul
Independent Director · since 2025
Surin Seubvongpataya
Independent Director · since 2025
Surasak Rounroengrom
Non-Executive Independent Director · since 2025
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||